A Phase III, open label, randomized, controlled, multicenter study to assess the safety and efficacy of the Study Drug monotherapy versus the physician’s choice to treat platinum-sensitive relapsed ovarian cancer.
Explore related content and topics
Blog
Ask the Experts: What Role Does Data Analytics Play in Clinical Research?
In light of World Statistics Day 2020, we’re exploring how trusted data can inform our world. To better understand how statisticians and data…
Read Story
Blog
Recommendations on Writing a Clinical Study Report for a Study Conducted During the COVID-19 Pandemic
The clinical study report (CSR) is a crucial document in the drug development and regulatory submission process that describes the background,…
Read Story
Case Study
Succeeding with a Risk-Based Approach
A Phase III double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of Drug A in patients with moderate to severe…
View Resource
View all related content and resources for Study Design
Explore Insights